Abstract

Background

Circular RNAs (circRNAs) play essential roles in cancer development and therapy resistance. Many studies have shown that circRNA is closely related to human health. The expression of circRNAs also affects the sensitivity of cells to drugs, thereby significantly affecting the efficacy of drugs. However, traditional biological experiments are time-consuming and expensive to validate drug-related circRNAs. Therefore, it is an important and urgent task to develop an effective computational method for predicting unknown circRNA-drug associations.

Results

In this work, we propose a computational framework (GATECDA) based on graph attention auto-encoder to predict circRNA-drug sensitivity associations. In GATECDA, we leverage multiple databases, containing the sequences of host genes of circRNAs, the structure of drugs, and circRNA-drug sensitivity associations. Based on the data, GATECDA employs Graph attention auto-encoder (GATE) to extract the low-dimensional representation of circRNA/drug, effectively retaining critical information in sparse high-dimensional features and realizing the effective fusion of nodes’ neighborhood information. Experimental results indicate that GATECDA achieves an average AUC of 89.18% under 10-fold cross-validation. Case studies further show the excellent performance of GATECDA.

Conclusions

Many experimental results and case studies show that our proposed GATECDA method can effectively predict the circRNA-drug sensitivity associations.

Details

Title
Predicting circRNA-drug sensitivity associations via graph attention auto-encoder
Author
Deng, Lei; Liu, Zixuan; Qian, Yurong; Zhang, Jingpu
Pages
1-15
Section
Research
Publication year
2022
Publication date
2022
Publisher
BioMed Central
e-ISSN
14712105
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2666304962
Copyright
© 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.